DINSMORE CHRISTOPHER (Chief Scientific Officer) sold 3.6% of their position (10.03K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $13.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/13/2023ACC: 0001209191-23-058465
Officer· Chief Scientific Officer
Since Oct 2020
-10.03K
Net shares
Net seller
$13.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.03K
Price / share
$1.30
Trade value
$13.09K
% of position
3.6%
12/12/2023
278.37K→268.33K
Total
Net shares
−10.03K
Net value
-$13.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2023 | S · Sale | −10.03K | $1.30 | $13.09K | 3.6% | 278.37K | 268.33K |
| Total | −10.03K | -$13.09K | ||||||
Derivative Transactions0
No derivative transactions reported